Exposure-based Treatment for Avoidant Back Pain Patients (ETABP)
This study is currently recruiting participants.
Verified November 2011 by Philipps University Marburg Medical Center
Sponsor:
Philipps University Marburg Medical Center
Collaborators:
Psychotherapie-Ambulanz Marburg e.V.
German Research Foundation
Information provided by (Responsible Party):
Julia Anna Glombiewski, Philipps University Marburg Medical Center
ClinicalTrials.gov Identifier:
NCT01484418
First received: November 28, 2011
Last updated: December 1, 2011
Last verified: November 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Chronic low back pain often results in psychosocial and physical disability. A subgroup of these patients shows fear of (re)injury and avoidance behaviour leading to higher disability. The purpose of this study is to determine whether exposure in vivo is more effective in the treatment of fear avoidant chronic back pain patients than psychological treatment as usual (cognitive behavioural psychotherapy).
| Condition | Intervention | Phase |
|---|---|---|
|
Low Back Pain |
Behavioral: Exposure in vivo Behavioral: Cognitive Behavioural Psychotherapy |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Exposure Therapy in Chronic Low Back Pain Patients |
Resource links provided by NLM:
Further study details as provided by Philipps University Marburg Medical Center:
Primary Outcome Measures:
- Change from baseline in pain severity at 3 and 6 months after admission [ Time Frame: from Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ] [ Designated as safety issue: No ]Numeric Rating Scale (NRS)
- Change from baseline in pain disability at 3 and 6 months after admission [ Time Frame: from Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ] [ Designated as safety issue: No ]Pain Disability Index (PDI) Quebec Back Pain Disability Scale (QBPDS)
Secondary Outcome Measures:
- Change in fear avoidance from Pretest to two in-between time points to Posttest [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ] [ Designated as safety issue: No ]Tampa Scale of Kinesiophobia (TSK) Pain Anxiety Symptom Scale (PASS)
- Change in pain catastrophizing from Pretest to two in-between timepoints to Posttest to Follow-up [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ] [ Designated as safety issue: No ]Pain Catastrophizing Scale (PCS)
- Change in emotional distress from Pretest to two in-between timepoints to Posttest to Follow-up [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ] [ Designated as safety issue: No ]Hospital Anxiety and Depression Scale (HADS)
- Change in quality of life from Pretest to two in-between timepoints to Posttest to Follow-up [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ] [ Designated as safety issue: No ]EuroQol (EQ-5D)
- Change in physical activity from Pretest to two in-between timepoints to Posttest to Follow-up Time [ Time Frame: from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission) ] [ Designated as safety issue: No ]International Physical Activity Questionnaire(IPAQ)
| Estimated Enrollment: | 100 |
| Study Start Date: | August 2011 |
| Estimated Primary Completion Date: | March 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: A Exposure long
Exposure in vivo for fear avoidant chronic low back pain patients. This treatment means that the individual is exposed to movements and tasks that have been avoided due to fear of (re)injury. The treatment begins after three educational lessons including the rational and developing a fear hierarchy. Exposure phase includes 10 exposures sessions which are highly individualized. Behavioral experiments can be included to correct catastrophic misinterpretations. The main purpose of this intervention type is to reduce pain related disability via diminishing fear avoidance.
|
Behavioral: Exposure in vivo
5-10 sessions based on an individualized fear hierarchy
|
|
Experimental: B Exposure short
See above exposure long. This treatment comprises 5 exposure sessions.
|
Behavioral: Exposure in vivo
5-10 sessions based on an individualized fear hierarchy
|
|
Active Comparator: C Cognitive behavioural psychotherapy
Cognitive behavioural psychotherapy for fear avoidant chronic low back patients. The therapy is modularized in three main parts. The educational lesson is followed by the module graded activity which represents the behavioral part of the program. The second module comprises relaxation. And the last part contains cognitive interventions. Cognitive behavioural intervention techniques are employed to support the patient in the process of coping with chronic pain: i.e. reduction of disability and improving functional ability.
|
Behavioral: Cognitive Behavioural Psychotherapy
graded activity, relaxation techniques and cognitive interventions
|
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Having at least 3 months back pain
- Sufficient level on fear avoidance scores (TSK, Phoda)
- Being German-speaking
- Agreeing to participate, verified by completion of informed consent
Exclusion Criteria:
- Red flags
- Pregnancy
- Illiteracy
- Psychoses
- Alcohol addiction
- surgeries during the last 6 months or planed surgeries
- Specific medical disorders or cardiovascular diseases preventing participation in physical exercise
- Participating in another psychotherapy
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01484418
Contacts
| Contact: Julia A Glombiewski, Dr. | 0049/6421/2823617 | jg@uni-marburg.de |
| Contact: Jenny Riecke | 0049/6421/2822837 | rieckej@staff.uni-marburg.de |
Locations
| Germany | |
| Philipps University Marburg, Department of Clinical Psychology and Psychotherapy | Recruiting |
| Marburg, Germany, 35037 | |
| Contact: Julia A Glombiewski, Dr. 0049/6421/2823617 jg@uni-marburg.de | |
| Contact: Jenny Riecke 0049/6421/2822837 rieckej@staff.uni-marburg.de | |
| Principal Investigator: Julia A Glombiewski, Dr. | |
| Sub-Investigator: Jenny Riecke | |
| Sub-Investigator: Sebastian Holzapfel | |
Sponsors and Collaborators
Philipps University Marburg Medical Center
Psychotherapie-Ambulanz Marburg e.V.
German Research Foundation
Investigators
| Study Director: | Winfried Rief, Prof. | Philipps University Marburg, Department of Clinical Psychology and Psychotherapy |
| Study Chair: | Julia A. Glombiewski, Dr. | Philipps University Marburg, Department of Clinical Psychology and Psychotherapy |
More Information
Additional Information:
No publications provided
| Responsible Party: | Julia Anna Glombiewski, Ph.D, Licensed Psychologist, Principal Investigator, Philipps University Marburg Medical Center |
| ClinicalTrials.gov Identifier: | NCT01484418 History of Changes |
| Other Study ID Numbers: | DFG-GL 607 |
| Study First Received: | November 28, 2011 |
| Last Updated: | December 1, 2011 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by Philipps University Marburg Medical Center:
|
Chronic Low Back Pain Cognitive Behavioural Therapy Exposure |
Fear avoidance Cognitive Behavioural Therapy in chronic low back pain Exposure in vivo in chronic low back pain |
Additional relevant MeSH terms:
|
Back Pain Low Back Pain Pain |
Neurologic Manifestations Nervous System Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 23, 2013